SCHEMBL9251373

SCHEMBL9251373

N=C(N)N1CCC(c2ccc(-c3csc(CCC(=O)O)n3)cc2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 7/20 0.44
ITGA2B P08514 7/20 0.44
ENPP2 Q13822 4/20 0.39
LMNA P02545 1/20 0.39
ALDH1A1 P00352 1/20 0.39
RAB9A P51151 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HDAC3 O15379 2/20 0.39
HDAC4 P56524 2/20 0.39
HDAC1 Q13547 2/20 0.39
HDAC7 Q8WUI4 2/20 0.39
HDAC2 Q92769 2/20 0.39
HDAC10 Q969S8 2/20 0.39
HDAC11 Q96DB2 2/20 0.39
HDAC8 Q9BY41 2/20 0.39
HDAC6 Q9UBN7 2/20 0.39
HDAC9 Q9UKV0 2/20 0.39
HDAC5 Q9UQL6 2/20 0.39
DGAT1 O75907 1/20 0.39
LOXL2 Q9Y4K0 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9251433 0.88 ITGB3 (0.42) ITGB3ITGA2BENPP2ALDH1A1RAB9A
SCHEMBL9253949 0.76 ITGB3 (0.52) ITGB3ITGA2BLMNAALDH1A1RAB9A
SCHEMBL21916047 0.74 NAMPT (0.36) ITGB3ITGA2BENPP2BCHE
SCHEMBL7826728 0.72 LOXL2 (0.64) LMNAALDH1A1RAB9AHDAC3HDAC4
SCHEMBL2229318 0.71 LMNA (0.57) LMNAALDH1A1RAB9AL3MBTL1HDAC3
SCHEMBL9257627 0.69 HDAC3 (0.44) ENPP2ALDH1A1RAB9AL3MBTL1HDAC3
SCHEMBL21495108 0.67 LOXL2 (0.65) LMNAALDH1A1RAB9AL3MBTL1HDAC3
SCHEMBL6000151 0.66 GCGR (0.41) RAB9AHDAC3HDAC4HDAC1HDAC7
SCHEMBL9408042 0.65 ITGB3 (0.51) ITGB3ITGA2BALDH1A1RAB9AHDAC3
SCHEMBL27025956 0.65 NOTUM (0.39) LMNAALDH1A1RAB9AHDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5463071-A Tetrazole derivatives; useful for inhibiting undesirable cell aggregation DR. KARL THOMAE GMBH (DE) 1995-10-31 US disclosed
EP-0525629-A2 5-membered heterocycles, process for their preparation and medicaments containing them Dr. Karl Thomae GmbH (DE) 1993-02-03 EP disclosed